Fierce Pharma Biopharma News & Insights
5 天之前 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
2022年7月18日 · Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were ...
FDA signs off on Merck’s potential blockbuster Winrevair for PAH
2024年3月26日 · Merck will charge $14,000 for a vial of Winrevair, which is dosed subcutaneously every three weeks, putting its annual cost at $238,000. Based on the label-recommended, weight-based target dose ...
Pharma | Fierce Pharma
2024年10月14日 · President-elect Donald Trump has named Johns Hopkins surgeon Martin Makary, M.D., as his choice for FDA commissioner during his upcoming term.
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
2018年9月28日 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
FDA approves first T-cell therapy for a solid tumor - Fierce Pharma
2024年2月17日 · Similar to existing CAR-T cell therapies, Amtagvi is manufactured using immune cells from individual patients. To make the final product, a patient’s TIL cells are collected from a portion of ...
Top 10 most anticipated drug launches of 2024 | Fierce Pharma
2024年1月29日 · Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...
First generics to Bristol-Myers and Pfizer's Eliquis are here. But can ...
2019年12月26日 · As Bristol's best-selling drug before the Celgene merger—even ahead of PD-1 inhibitor Opdivo—the drug delivered $5.9 billion to the company’s top line in the first nine months of 2019.